Detalhe da pesquisa
1.
High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
Proc Natl Acad Sci U S A
; 119(31): e2205042119, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881799
2.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940409
3.
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Mult Scler
; 30(4-5): 558-570, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436271
4.
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.
J Sleep Res
; : e14164, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351662
5.
Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia.
Ann Neurol
; 91(5): 676-681, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170072
6.
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
Ann Neurol
; 91(6): 814-820, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293622
7.
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 726-737, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076291
8.
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
J Magn Reson Imaging
; 58(3): 864-876, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708267
9.
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
Mult Scler
; 29(13): 1540-1550, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772490
10.
Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis.
Eur J Neurol
; 30(7): 1919-1927, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029777
11.
Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis.
Eur J Neurol
; 30(12): 3809-3818, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37578431
12.
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Eur J Neurol
; 30(5): 1389-1399, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779855
13.
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes.
Biomarkers
; 28(3): 341-351, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714921
14.
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials.
BMC Med Res Methodol
; 23(1): 84, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020207
15.
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
J Peripher Nerv Syst
; 28(1): 86-97, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471582
16.
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
Blood Cells Mol Dis
; 97: 102689, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780678
17.
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019.
Ann Neurol
; 89(3): 610-616, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33377539
18.
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
Ann Neurol
; 90(3): 477-489, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34057235
19.
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event.
Mult Scler
; 28(1): 71-81, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870790
20.
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS.
Mult Scler
; 28(4): 573-582, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378446